Dysregulation of the Epigenome in Human Disease
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, November 13, 2008
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium/Montefiore Medical Center
John M. Greally, M.B., B.Ch., Ph.D.
Associate Professor, Departments of Genetics and Medicine (Hematology)
Dr. John Greally has been on the Albert Einstein College of Medicine faculty since 2001. A native of Ireland, Dr. Greally received his degree in Medicine from the National University of Ireland in Galway (NUIG) in 1988, subsequently moving to the Children’s Hospital of Pittsburgh for Pediatrics residency and Yale University in 1993 for subspecialty training in Clinical Genetics. Since his clinical training, he focused on basic science research, receiving his PhD degree in 1999 from NUIG.
Dr. Greally’s research is in the area of epigenomic regulation of the genome, and its dysregulation in disease. Dr. Greally directs the Einstein Center for Epigenomics, and serves on the editorial board of the new journal Epigenetics and Chromatin and as a member of steering group established by the American Association for Cancer Research to establish an international human epigenome project.
After attending this activity, participants will be able to:
1. Understand how genes normally switch on and off under epigenetic control
2. Understand what the mediators of the epigenetic control are and learn how they can be studied with today’s technology
3. Learn how these technologies are revealing insights into human diseases such as cancer
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.